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     Growing evidence suggests that serotonin plays an important role in learning and memory and all its 
receptors might be implicated in this process. The present study aimed at investigating and comparing the 
possible involvement of 5-HT3 and 5-HT4 receptor (R) agonists/antagonists upon consolidation of 
inhibitory avoidance memory in the pre-limbic (PL) area. Bilateral intra-PL microinjections of m-CPBG 
(m-Chlorophenylbiguanide hydrochloride: a selective 5-HT3R agonist; 0.1 μg/rat), Y-25130 (a selective 
5-HT3R antagonist; 0.1 μg/rat), RS67333 (a potent and highly selective 5-HT4R partial agonist; 0.5 
μg/rat) and RS23597-190 (a selective 5-HT4R antagonist; 0.5 μg/rat) were performed immediately after 
training. The step-through inhibitory avoidance (IA) task was used to memory assessment in adult male 
Sprague-Dawley rats. Our data revealed that the post-training intra-PL microinjection of m-CPBG 
relative to saline and Y-25130 decreased inhibitory avoidance memory consolidation in the PL area. On 
the contrary, RS67333 increased IA memory consolidation in comparison to saline and RS23597-190. In 
addition, there was also a significant difference between the effects of m-CPBG and RS67333 on IA 
memory consolidation in the PL area. M-CPBG induced reduction of IA memory consolidation, while 
RS67333 increased it. However, Y-25130 compared to RS23597-190 did not show any significant 
difference. All above interventions did not alter locomotor activity. This study indicated that local direct 
agonist activation of 5-HT3Rs induced the reduction of IA memory consolidation, opposed to the local 
direct agonist activation of 5-HT4Rs, which mediated enhancement of IA memory consolidation. It can be 
proposed that 5-HT3Rs in comparison to 5-HT4Rs may be inversely involved in modulation of IA 
memory consolidation in the PL. 
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INTRODUCTION 
     The serotonergic system is widely distributed 
in the central nervous system (CNS) and plays an 
important role in various cognitive and non-
cognitive behavioral and physiological processes 
including appetite, food intake, pain perception, 
mood, activity rhythm, sleep, learning and 
memory, stress, anxiety and behavioral inhibition 
or emotional states [1, 2]. The role of serotonin 
(5-HT) in learning and memory has been of great 
interest in neuroscience as it plays a critical role 
in mediating short- and long-term memory. 
Studies have revealed that 5-HT pathways, 5-HT 
reuptake site/transporter complex and 5-HT 
receptors (5-HTRs) indicate regional distribution 
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in regions of the brain that are associated with 
learning and memory [2-4]. The 5-HT mediates 
its effects through seven distinct families of 5-
HTRs with different functional properties. Except 
5-HT3R as a ligand-gated ion channel, the others 
belong to the G-protein coupled receptor 
superfamily [5].  
In the CNS, the 5-HT3Rs are expressed in the 
spinal cord, medulla oblongata, hindbrain, the 
forebrain (such as cerebral cortex, hippocampus 
and amygdala), striatum, nucleus accumbens and 
substantia nigra [6, 7]. It has been demonstrated 
that activation and blockade of 5-HT3Rs may be 
involved in learning impairment and 
enhancement, respectively [8, 9]. 5-HT3R 
antagonists seem to have procognitive effects and 
are able to improve memory acquisition in Y-
maze and passive avoidance tasks [10] and spatial 
learning in a two-platform spatial discrimination 
task [11]. In contrast, 5-HT3R agonists have 
opposite effects and cause memory deficits [9, 
12].  5-HT4Rs belong to G-protein coupled 7-
transmembrane domain receptor superfamily 
[13], coupled with Gs protein subunit [14], which 
facilitate the release of various neurotransmitters 
through blockage of potassium channels and 
subsequent mobilization of calcium ions [15]. 
Wide and heterogeneous regional distributions of 
5-HT4Rs have been reported in the brain limbic 
areas, representing the critical role of 5-HT4Rs in 
memory function [16-19]. The importance of 5-
HT4Rs in memory processes is further 
emphasized through various studiesmanifesting 
that 5-HT4 agonists improve learning and 
memory, either alone [20-23] or in combination 
with the other pharmacological agents [20]. 
Based on the studies, it seems that these receptors 
mediate various responses on different stages of 
memory formation dependent on the method of 
injection and memory assessment [9, 24, 25]. 
Presence of 5-HT3R [26] and 5-HT4R [27] has 
been reported in the pre-limbic (PL) area. PL 
cortex is a subdivision of medial prefrontal cortex 
(mPFC) [28], serving as an important role in 
modulation of aversive memory [29]. So, this 
study aimed at comparing the possible role of 
intra-PL micro-infusions of 5-HT3 and 5-HT4 
receptor agonists/antagonists immediately after 
training, upon consolidation of aversive memory,  
 
using the inhibitory (passive) avoidance task. 
MATERIALS AND METHODS 
Animals 
     In this study, adult male Sprague-Dawley rats 
(250-290 g, purchased from the Center of 
Comparative and Experimental Medicine, Shiraz 
University of Medical Sciences, Shiraz, Iran) 
were used. Animals (four rats/cage) were 
maintained in the animal room under a 12/12-h 
light/dark cycle (lights on 07:00 hours) and 
controlled temperature of 22±2 °C. Animals had 
free access to food and water and were adapted to 
the laboratory conditions for at least one week 
prior to the surgery. Animal handling was limited 
to the time of home cage cleaning (each 48 h), 
weighing, and drugs administration only. The 
experiments were conducted between 9:00 am 
and 14:00 pm. Each experimental group included 
eight animals and each animal was used once 
only. The experiments were done in accordance 
with the guide for the care and use of laboratory 
animals (N.R.C., 2011) [30].  
Stereotaxic surgery  
     The animals were anesthetized by intra-
peritoneal injection of ketamine hydrochloride 
10% (70 mg/kg) plus xylazine 2% (7 mg/kg), and 
positioned in a stereotaxic frame (Stoelting Co., 
Wood Dale, Illinois, USA). Then, using the rat 
brain atlas by Paxinos and Watson [31] and to 
aim the PL cortex (AP = +3.4 mm, ML = ±0.9 
mm, and DV = −3 mm; Figure), two stainless 
steel guide-cannulas (22-gauge) with a length of 
10.0 mm were bilaterally implanted and fixed to 
the skull bone. Animals were allowed to recover 
from the surgery for one week. 
Behavioral Tests 
Inhibitory (passive) avoidance task / 
measurement of memory 
     The step-through inhibitory avoidance (IA) 
task was performed as previously described [32, 
33]. In this task, animals learn to avoid and 
suppress their natural tendency to prefer specific 
places because of an aversive experience. A 
learning box consisted of two compartments 
separated by a sliding door (7 cm × 9 cm). A light 
compartment (20 cm × 20 cm × 30 cm) was made 
of white opaque resin, and a dark compartment 
(20 cm × 20 cm × 30 cm) was made of black 
opaque resin. Stainless steel grids were placed on  
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the dark compartment floor to deliver a foot 
shock. Intermittent mild electric shocks (Intensity 
=0.7 mA, Frequency=50 Hz, Duration=3 s) were 
delivered to the grid floor by an isolated 
stimulator (Borj Sanat Co., Tehran, Iran). 
All animals were allowed to habituate to the 
experimental room, at least half an hour prior to 
experiments. Then, animals were individually 
placed in the bright compartment and allowed to 
explore for 15 s. Then, the sliding door was 
opened and once the animal crossed with all four 
paws to the dark compartment, the sliding door 
was closed and the latency to enter the dark 
compartment was recorded and the animal 
immediately was returned into its home cage. 
Animals that waited for more than 120 s to cross 
to the dark compartment were excluded. After 30 
min during PA training, the habituation trial was 
repeated for each animal except that an 
unavoidable foot shock was immediately 
delivered from the grid floor, as soon as the 
animal crossed to the dark compartment. After 15 
s, the animal was removed from the apparatus 
and retested 2 min later in the same way as in the 
previous trials. If the rat did not enter the dark 
compartment within 120 s, a successful learning 
(IA response) was recorded; otherwise, the 
animal received the shock again, as soon as it 
crossed to the dark compartment. Each animal 
was allowed to train up to three times. Animals 
that could not acquire successful learning were 
excluded. After successful acquisition, the animal 
immediately received post-training injection of 
the drugs. After 24 h, during retention session, 
the animal was gently placed in the light 
compartment once more, and the step-through 
latency or latency to enter the dark compartment 
(with a cut off time of 300s) was recorded which 
was considered as an index of the IA memory 
consolidation. Post-training drug administration 
used in order to assess the impact of drugs on 
emotional memory consolidation. 
Locomotion test 
     Locomotor activity was assessed by an animex 
activity meter apparatus (Type DS, Farad 




retention trial session. Animals were individually 
placed on the measurement platform, and allowed 
to freely explore for a duration of 5 min; the 
number of animal movements was automatically 
recorded.  
Drugs  
     The drugs used in this study included: m-
Chlorophenylbiguanide hydrochloride (m-CPBG; 
a prototypical potent and selective 5-HT3 
serotonin receptor agonist, 0.1 µg/rat), Y-25130 
hydrochloride (a selective and potent 5-HT3 
serotonin receptor antagonist, 0.1 µg/rat), 
RS67333 hydrochloride (1-(4-amino-5-chloro-2-
methoxyphenyl)-3-[1-butyl-4-piperidinyl]-1-
propanone hydrochloride; a potent and highly 
selective 5-HT4 partial agonist, 0.5 μg/rat) and RS 
23597-190 hydrochloride (3-(piperidin-1-yl) 
propyl 4-amino-5-chloro-2-methoxybenzoate 
hydrochloride; a high affinity, selective 
competitive antagonist at 5-HT4Rs, 0.5 μg/rat). 
They all were obtained from Tocris (Tocris 
Bioscience United Kingdom). Ketamine 
hydrochloride / xylazine (Alfasan Chemical Co, 
Woerden, Holland) was used for inducing 
anesthesia. The infusion time and doses of the 
drugs used in this study were chosen according to 
the published work in scientific literature [32] 
and unpublished studies at our laboratory. 
Intra-PL microinjection procedures 
     For a bilateral infusion of the drugs into the 
PL area, the animals were restrained gently by 
hand; the stylets were removed from the guide 
cannulae and substituted by infusion needles (27-
gauge). The injection needles were advanced 
until their tips reached 1 mm below the tip of the 
guide cannulae. Then, solutions were manually 
injected in a total volume of 0.6 μl/rat (0.3 μl in 
each side) over a 60 s period, using a 2-μl 
Hamilton glass syringe. A polyethylene tube was 
interposed between the upper end of dental 
needles and the micro-syringes. The displacement 
of an air bubble inside the polyethylene tube was 
used to monitor the drug flow. To facilitate the 
diffusion of the drugs and to allow proper 
infusion, needles were removed 60 s after the 










     Animals were randomly assigned to five 
groups (n=8). One group received saline (0.6 
μl/rat) and the other four groups received m-
CPBG (0.5 μg/rat), Y-25130 (0.5 μg/rat), 
RS67333 (0.5 μg/rat) or RS23597-190 (0.5  
μg/rat). The drugs were dissolved in 0.9% sterile 
saline. Bilateral intra-PL microinjection of the 
drugs in a volume of 0.6μl/rat (0.3μl/side) was 
performed immediately after a training session. 
24 hours following the drug administration, 
behavioral tests (passive avoidance & locomotor 
activity) were performed in all groups. 
Histological study 
     To verify the correct cannulae placements 
according to the atlas of Paxinos and Watson 
[31], 1% methylene blue dye solution was 
injected (0.3-μl/side), followed by coronal 
sectioning on the vibroslice after the completion 
of the experiments. If the cannulae placement was 
outside the PL region, the data of the rat was 
excluded from the analysis. 
Statistical analysis 
     The normal distribution of data was assessed 
by the Kolmogorov– Smirnov test. One-way 
ANOVA and Tukey’s post-hoc tests were used 
for data analysis. To compare the effects of 5-
HT3R and 5-HT4R agonists/antagonists on IA 
memory consolidation in the PL area, first the 
percentage change of control for each rat 
(treatment/mean control×100) was calculated and 
then the difference in mean of percentage change 
of control between groups were analyzed by one 
way ANOVA. Tukey’s post-hoc analysis, 
following a significant F value, was performed to 
evaluate the paired-group comparisons. SPSS 
software ver. 16 was used for all statistical 
analysis and P < 0.05 was considered as a 
significant level.  
RESULTS 
Effect of post-training intra-PL administration 
of 5-HT3 and 5-HT4 receptor agonists / 
antagonists on the inhibitory avoidance memory 
consolidation  
     One-way ANOVA demonstrated that post-
training intra-PL administration of the drugs 
significantly altered memory consolidation [F (4, 
35) = 20.262, P < 0.0005, (Fig. 1A)] but did not 
affect locomotor activity [F (4, 35) = 0.637, P = 
0.639, (Fig. 1B)]. Moreover, tukey post hoc 
analysis showed that sole intra-PL microinjection 
of m-CPBG impaired IA memory consolidation, 
whereas RS67333 increased it, compared with the 
saline control group. In addition, mere Y-25130 
and RS23597-190 did not affect the IA memory 
consolidation. Moreover, a comparison between 
the two receptors in one-way ANOVA 
demonstrated that post-training intra-PL 
administration of the drugs significantly altered 
memory consolidation [F(3,28) = 30.657, P < 
0.0005, (Fig. 2A)] but did not affect locomotor 
activity [F(3,28) = 0.100, P = 0.959, (Fig. 2B)]. 
Tukey’s post hoc analysis showed that 5-HT3R 
agonist (m-CPBG) relative to 5-HT3R antagonist 
(Y-25130) decreased IA memory consolidation in 
the PL area. Moreover, 5-HT4R agonist 
(RS67333) significantly increased IA memory 
consolidation in comparison with 5-HT4R 
antagonist (RS23597-190). Tukey’s post hoc 
analysis also demonstrated that there was also a 
significant difference between the effects of m-
CPBG and RS67333 on IA memory consolidation 
in the PL area. In addition, Y-25130 compared to 
RS23597-190 did not show any significant 
difference. In summary, the results indicated that  
5-HT3R agonist acts opposed to the 5-HT4R 
agonist on IA memory consolidation in the PL 









































































































































































































     Our results revealed that there was a 
significant difference between the effects of the 
5-HT3 and 5-HT4 receptor agonists on the 
inhibitory avoidance memory consolidation in the 
PL area, while their antagonists did not have 
significant difference. The present results 
indicated that m-CPBG (5-HT3R agonist) in 
comparison to saline, Y-25130 (5-HT3R 
antagonist) and RS67333 (5-HT4R agonist) 
reduced IA memory consolidation in the PL 
cortex. In this regard, in previously published 
work we had shown that the post training intra-
PL microinjection of mCPBG at a dose of 0.1 
μg/rat decreased IA memory consolidation [32], 
whereas Y-25130 did not alter memory 
consolidation. Also, consistent with these results, 
it has been reported that administration of m-
CPBG impaired learning and memory process 
and induced amnesia in the passive avoidance [4, 
35], autoshaping [9] and associative learning [36] 
tasks.  
Figure.2. Comparison of 5-HT3 or 5-HT4 agonists and 
antagonists function on IA memory consolidation (A) 
and locomotor activity (B) in rats 
Bars represent mean of percent change of control ± 
S.E.M. ***P<0.001, different from Y-25130 treatment 
group. +P<0.05, different from RS623597-190 
treatment group. ΨΨΨP<0.001, different from 
RS67333 treatment group. 
Figure.1.  Effects of the post-training intra-PL 
microinjections of m-CPBG, Y-25130, RS67333 and 
RS23597-190 on IA memory consolidation (A) and 
locomotor activity (B) in rats. Five groups of animals 
were used. one group received saline (0.6 μl/rat) and 
the other Four groups received m-CPBG (0.1 μg/rat) 
or Y-25130 (0.1 μg/rat) or RS67333 (0.5 μg/rat) or 
RS23597-190 (0.5 μg/rat) immediately after training. 
Step through latency and locomotor activity were 
examined in all groups, after 24h. Each bar represents 
mean ± SEM. ***P<0.001 and +P<0.05, different 
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The present results also indicated that local 
application of 5-HT4 receptor selective agonist 
(RS67333) in the PL area in comparison to saline 
and its selective antagonist (RS23597-190) 
increased IA memory consolidation. In line with 
our results, it has been reported that 
intraperitoneal infusions of RS67333 increases 
place and object recognition memory 
consolidation in a two-trial recognition test [20] 
and enhance both short and long term memory in 
the autoshaping learning task [9]. Likewise, Intra-
nucleus accumbens (NAc) shell administration of 
RS67333 also increased memory consolidation in 
the elevated plus-maze (EPM) test [37] and its 
antagonist, RS23597-190, decreased memory 
consolidation. It has been shown that local intra-
nucleus basalis magnocellularis (NBM) 
administration of RS67333 induced enhancement 
of the acquisition and the consolidation of the 
place recognition memory in a place recognition 
task, but the recall of memory was not affected by 
the 5-HT4 agonist [24]. Although, much evidence 
has supported the facilitating role of RS67333 in 
memory processing, some studies report that 
RS67333 impairs context or tone fear memory 
consolidation in a fear conditioning apparatus 
[38], reduces memory acquisition in a single-trial 
step-down passive avoidance task [25] and 
induces emotional memory impairment in the 
EPM test-retest paradigm [39]. It seems that 
activation of 5-HT4Rs exerts varying effects at 
different stages (acquisition, consolidation and 
retrieval) of memory formation, depending on the 
type of the drugs used, the site of administration 
(central vs. systemic), timing of the drug 
administration, and memory assessment. 
Notably, the present results probably illustrate the 
existence of an inverse relationship between the 
effects of 5-HT3 and 5-HT4Rs on memory 
consolidation in the PL. It appears that different 
mechanisms are involved in the incidence of 
these differences. Evidence from invertebrates to 
human studies demonstrates that the serotonergic 
system involved in modulation of short and long 
term memory function and the opposite findings 
has also been reported [9]. Linkage to second 
messengers and anatomical, cellular and 
subcellular locations of receptors are at least two 
criteria that need to be considered in defining the 
role of a receptor in the memory process. It has 
been demonstrated that the 5-HTRs are either 
positively or negatively coupled to adenylate 
cyclase (AC) enzyme and influence cyclic 
adenosine monophosphate (cAMP) production. 
cAMP initiates activation of other molecules 
implicated in memory process by facilitation or 
the blockade of protein synthesis [2]. So, it is 
possible that the effects of 5-HT4Rs in the 
enhancement of IA memory consolidation in the 
PL cortex are due to the followings: 
1. 5-HT4Rs is predominantly localized into limbic 
structures linked to memory and cognition. The 
5-HT4Rs expression has been reported in ~60% 
of pyramidal neurons of the prefrontal cortex 
(PFC) [40]. Lucas et. al. also demonstrated the 
presence of 5-HT4Rs in the PL sub-region of 
mPFC, by in situ hybridization histochemistry 
[41]. 2. 5-HT4Rs are linked to Gs proteins and 
their activation induced cAMP production [42].  
3. 5-HT4Rs mediated various neurotransmitter 
release (dopamine, serotonin, GABA and 
acetylcholine) and facilitate synaptic transmission 
which may influence memory development [43, 
44].On the other hand, it is thought that the 
effects of 5-HT3Rs on memory consolidation, at 
least in part, is also related to their structural and 
functional characteristics. The 5-HT3R, as a 
ionotropic ion channel, is primarily present on 
presynaptic nerve terminals [45, 46], and is 
permeable to Na+, K+ and Ca++ ions [47]. Its 
selective agonist activation by conducting 
cations, most notably Ca2+, leads to an excitatory 
response in neurons and is involved in mediation 
or modulation of other neurotransmitter release 
[1]. In non-primate mammals, the 5-HT3Rs are 
expressed in the limbic areas in particular 
cingulate, prelimbic and infralimbic areas [1, 7]. 
Interestingly, the vast majority of 5-HT3R-
expressing cells in the prelimbic cortex are 
GABAergic interneurons, as assessed by in situ 
hybridization [26, 48]. It seems that local direct 
agonist activation of 5-HT3Rs, which probably is 
located on inhibitory GABAergic interneurons, 
via the initiation of inhibitory postsynaptic 
potentials (IPSPs) in cortical pyramidal neurons 
[1, 49], negatively participate in the modulation 
of memory consolidation in the PL subregion of 
medial prefrontal cortex. However, further 
experiments are required to clarify the exact 
mechanisms involved. In conclusion, our results 
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revealed that local direct agonist activation of 5-
HT3Rs induced the reduction of IA memory 
consolidation, while local direct agonist 
activation of 5-HT4Rs mediates the enhancement 
of IA memory consolidation. In summary, it can 
be proposed that 5-HT3Rs in comparison to 5-
HT4Rs may be inversely involved in modulation 
of inhibitory avoidance memory consolidation in 
the pre-limbic area. 
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